Eton Pharmaceuticals Capital Expenditures Over Time

ETON Stock  USD 15.03  0.67  4.27%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Eton Pharmaceuticals Performance and Eton Pharmaceuticals Correlation.
To learn how to invest in Eton Stock, please use our How to Invest in Eton Pharmaceuticals guide.
  
As of the 5th of March 2025, Capital Expenditures is likely to grow to about 1.4 M.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eton Pharmaceuticals. If investors know Eton will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eton Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.13)
Earnings Share
(0.26)
Revenue Per Share
1.219
Quarterly Revenue Growth
(0.24)
Return On Assets
(0.12)
The market value of Eton Pharmaceuticals is measured differently than its book value, which is the value of Eton that is recorded on the company's balance sheet. Investors also form their own opinion of Eton Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Eton Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eton Pharmaceuticals' market value can be influenced by many factors that don't directly affect Eton Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eton Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eton Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eton Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Capital Expenditures Analysis

Compare Eton Pharmaceuticals and related stocks such as Connect Biopharma, Acumen Pharmaceuticals, and Nuvation Bio Capital Expenditures Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Shareholders Equity Per ShareDebt To Equity
Capex Per ShareGraham Net Net
Average ReceivablesRevenue Per Share
Interest Debt Per ShareDebt To Assets
Enterprise Value Over E B I T D AShort Term Coverage Ratios
Price Earnings RatioOperating Cycle
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Cash Conversion CycleOperating Cash Flow Sales Ratio
Days Of Inventory OutstandingDays Of Sales Outstanding
Free Cash Flow Operating Cash Flow RatioCash Flow Coverage Ratios
Price To Book RatioFixed Asset Turnover
Capital Expenditure Coverage RatioPrice Cash Flow Ratio
Enterprise Value MultipleDebt Ratio
Cash Flow To Debt RatioPrice Sales Ratio
Return On AssetsAsset Turnover
Net Profit MarginGross Profit Margin
Price Fair ValueReturn On Equity
2010201120122013201420152016201720182019202020212022202320242025
CNTB1.2 M1.2 M1.2 M1.2 M1.2 M1.2 M1.2 M1.2 M1.2 M1.1 M2.3 M47.5 M4.3 M294 K338.1 K321.2 K
ABOS40 K40 K40 K40 K40 K40 K40 K40 K40 K40 K40 K40 K161 K21 K24.1 K22.9 K
NUVB659 K659 K659 K659 K659 K659 K659 K659 K659 K659 K145 K282 K370 K69 K62.1 K59 K
ELDNKKK23 K25 K565 K17 K0.00.00.00.00.00.00.00.00.0
INBX215 K215 K215 K215 K215 K215 K215 K1.3 M1.4 M1.8 M1.4 M864 K686 K4.6 M5.3 M5.5 M
CELC79 K79 K79 K79 K79 K79 K40.9 K239.8 K629.6 K380.2 K89.4 K81.9 K158.8 K97.6 K87.9 K159.8 K
ELVN0.00.00.00.00.00.00.00.00.0140 K461 K191 K612 K149 K171.3 K244 K
REPL238 K238 K238 K238 K238 K238 K238 K136 K2.6 M6.5 M2.4 M2.3 M2.3 M5.7 M6.5 M6.8 M
NVCT0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
LYRA37 K37 K37 K37 K37 K37 K37 K37 K37 K211 K1.8 M3.4 M164 KM1.2 M1.2 M
KRON1.1 M1.1 M1.1 M1.1 M1.1 M1.1 M1.1 M1.1 M1.1 M2.9 M9.6 M4.3 M577 K679 K611.1 K580.5 K
GOSS3.5 M3.5 M3.5 M3.5 M3.5 M3.5 M3.5 M3.5 M21.2 M6.6 M24.9 M1.6 M475 K0.00.00.0
TARSKKKKKKKKK175 K456 K586 K506 K1.5 M1.6 M1.6 M
ALDX0.00.00.00.014.1 K86.1 K11.8 K24.8 K263 K9.5 K7.8 K7.8 K16.3 K2.00.00.0
TVTX0.00.01.2 M5.5 MMM11.9 M14 M19.7 M15.6 M119.8 M24.2 M28.6 M668 K101.2 M106.3 M
PASG2.5 M2.5 M2.5 M2.5 M2.5 M2.5 M2.5 M2.5 M2.5 M1.7 M1.6 M25.6 M5.3 M146 K34 K32.3 K
BDTX77 K77 K77 K77 K77 K77 K77 K77 K76 K21 K142 K2.7 M192 K33 K38 K36.1 K
ALEC2.2 M2.2 M2.2 M2.2 M2.2 M2.2 M2.2 M801 K1.9 M15.3 MM3.2 M4.1 M2.4 M1.3 M1.2 M

Eton Pharmaceuticals and related stocks such as Connect Biopharma, Acumen Pharmaceuticals, and Nuvation Bio Capital Expenditures description

Capital Expenditures are funds used by Eton Pharmaceuticals to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Eton Pharmaceuticals operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

My Equities

My Current Equities and Potential Positions

Eton Pharmaceuticals
ETON
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
LocationIllinois; U.S.A
ExchangeNASDAQ Exchange
USD 15.03
When determining whether Eton Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eton Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eton Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eton Pharmaceuticals Stock:
Check out Eton Pharmaceuticals Performance and Eton Pharmaceuticals Correlation.
To learn how to invest in Eton Stock, please use our How to Invest in Eton Pharmaceuticals guide.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Eton Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Eton Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Eton Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...